(Q48328920)
Statements
1 reference
Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease. (English)
1 reference
K-L Kolho
1 reference
T Ruuska
1 reference
E Savilahti
1 reference
1 January 2007
1 reference
1 reference
96
1 reference
1
1 reference
128-130
1 reference